SCHEMBL11894690

SCHEMBL11894690

CCOc1cc(C(=O)O)c2c(ccc3nn(-c4ccccc4)nc32)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.43
▸ MAPT P10636 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ HTR3E A5X5Y0 1/20 0.40
▸ HTR3B O95264 1/20 0.40
▸ HTR3A P46098 1/20 0.40
▸ HTR3D Q70Z44 1/20 0.40
▸ HTR3C Q8WXA8 1/20 0.40
▸ BCL2 P10415 1/20 0.39
▸ MDM2 Q00987 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ NPC1 O15118 6/20 0.38
▸ RAB9A P51151 5/20 0.38
▸ SMN1; SMN2 Q16637 7/20 0.38
▸ KDM4E B2RXH2 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 4/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11895582 0.74 PARP1 (0.51) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11894712 0.74 KDM4E (0.41) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11894887 0.73 PARP1 (0.43) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL9203821 0.73 KDM4E (0.64) MAPTRXFP1HTR3EHTR3BHTR3A
SCHEMBL11894892 0.72 KDM4E (0.57) MAPTRXFP1MCL1KDM4EALDH1A1
SCHEMBL11894745 0.72 KDM4E (0.55) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11895065 0.70 PARP1 (0.36) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11895162 0.70 CYP19A1 (0.41) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL11895208 0.70 ALDH1A1 (0.48) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL11895094 0.70 CYP19A1 (0.41) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2487175-A1 PHARMACEUTICAL PRODUCT CONTAINING AROMATIC HETEROCYCLIC COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2012-08-15 — — EP disclosed
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196854-A1 PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND CYP2C18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP2B6 PARP1 3986/4885MAPT 2243/4885RXFP1 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback